Back to top

Cerebras Systems Climbs Ahead of Q2 Results as Investors Focus on Growth Pipeline

Cerebras Systems (CBRS) is up 6.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied mainly to positioning ahead of the company’s second-quarter 2026 earnings release scheduled for after the market close on August 12, 2026. Investor sentiment also seems supported by Cerebras’ strong first-quarter growth, its full-year revenue outlook, and a series of recent AI infrastructure partnerships that reinforced its expansion story.

Details:

  • Cerebras said it would report second-quarter 2026 financial results after the close on August 12, setting up a near-term catalyst that often drives speculative buying.
  • In its most recent quarterly update, the company posted first-quarter revenue growth of 94% year over year on a GAAP basis and guided for about $194 million of core revenue in Q2, while maintaining full-year core revenue guidance of $855 million to $865 million.
  • The company recently announced a technical partnership with AMD to pair AMD Helios systems with Cerebras Wafer-Scale Engine technology for AI inference, with an initial cloud rollout expected in the second half of 2026.
  • Cerebras also announced a strategic partnership with CrowdStrike focused on AI-powered security workloads, which may have added to enthusiasm around commercial adoption of its inference platform.
  • Sources:

    Cerebras, SEC, Stock Analysis

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $CBRS Insider Trading Activity

    CBRS Insider Trades

    $CBRS insiders have traded $CBRS stock on the open market 130 times in the past 6 months. Of those trades, 0 have been purchases and 130 have been sales.

    Here’s a breakdown of recent trading of $CBRS stock by insiders over the last 6 months:

    • DHIRAJ MALLICK (Chief Operating Officer) has made 0 purchases and 58 sales selling 79,445 shares for an estimated $14,117,476.
    • ANDREW D. FELDMAN (CEO, President) has made 0 purchases and 12 sales selling 17,990 shares for an estimated $3,113,282.
    • YAGNESH PATEL (Chief Accounting Officer) has made 0 purchases and 44 sales selling 10,079 shares for an estimated $1,739,513.
    • SEAN LIE (Chief Technology Officer) has made 0 purchases and 16 sales selling 10,033 shares for an estimated $1,706,311.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    EARLY ACCESS
    Receive CBRS Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $CBRS Hedge Fund Activity

    We have seen 206 institutional investors add shares of $CBRS stock to their portfolio, and 0 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • ECLIPSE OPERATIONS, LLC added 11,446,270 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,529,625,670
    • CAPITAL WORLD INVESTORS added 3,894,458 shares (+inf%) to their portfolio in Q2 2026, for an estimated $860,675,218
    • BLACKROCK, INC. added 2,075,168 shares (+inf%) to their portfolio in Q2 2026, for an estimated $458,612,128
    • CAPITAL RESEARCH GLOBAL INVESTORS added 883,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $195,143,000
    • NORGES BANK added 846,636 shares (+inf%) to their portfolio in Q2 2026, for an estimated $187,106,556
    • WASHINGTON UNIVERSITY added 551,086 shares (+inf%) to their portfolio in Q2 2026, for an estimated $121,790,006
    • GEODE CAPITAL MANAGEMENT, LLC added 399,695 shares (+inf%) to their portfolio in Q2 2026, for an estimated $88,332,595

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $CBRS Analyst Ratings

    Wall Street analysts have issued reports on $CBRS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Needham issued a "Buy" rating on 06/08/2026

    To track analyst ratings and price targets for $CBRS, check out Quiver Quantitative's $CBRS forecast page.

    $CBRS Price Targets

    Multiple analysts have issued price targets for $CBRS recently. We have seen 11 analysts offer price targets for $CBRS in the last 6 months, with a median target of $300.0.

    Here are some recent targets:

    • Paul Meeks from Freedom Capital Markets set a target price of $209.0 on 06/30/2026
    • N. Quinn Bolton from Needham set a target price of $300.0 on 06/24/2026
    • Matt Bryson from Wedbush set a target price of $280.0 on 06/24/2026
    • Joseph Moore from Morgan Stanley set a target price of $273.0 on 06/24/2026
    • Kevin Cassidy from Rosenblatt set a target price of $300.0 on 06/24/2026
    • Timothy Arcuri from UBS set a target price of $320.0 on 06/24/2026
    • Richard Shannon from Craig-Hallum set a target price of $325.0 on 06/09/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Read full article here »

    In-Depth Zacks Research for the Tickers Above

    Normally $25 each - click below to receive one report FREE: